Trial Profile
Tolerability of switching from warfarin to edoxaban in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Sep 2012
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Warfarin
- Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism
- Focus Adverse reactions; Biomarker
- Sponsors Daiichi Sankyo Company
- 29 Sep 2012 New trial record